We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
+11.21%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$255M
AUM Growth
–
Cap. Flow
+$243M
Cap. Flow
% of AUM
95.38%
Top 10 Holdings %
Top 10 Hldgs %
38.34%
Holding
87
New
87
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$14.7M |
| 2 |
Becton Dickinson
BDX
|
+$11.7M |
| 3 |
AGN
Allergan plc
AGN
|
+$9.93M |
| 4 |
Encompass Health
EHC
|
+$9.24M |
| 5 |
Elevance Health
ELV
|
+$9.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 85.71% |
| 2 | Technology | 1.03% |
| 3 | Financials | 0.67% |
| 4 | Consumer Staples | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
26
DELISTED
St Jude Medical
STJ
| $2.97M | 1.17% |
+45,731
| New | +$2.95M |
|
|
COV
27
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $2.94M | 1.15% |
+28,750
| New | +$2.76M |
|
|
ASPX
28
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $2.83M | 1.11% |
+53,950
| New | +$1.58M |
|
29
Boston Scientific
BSX
$69.5B
| $2.83M | 1.11% |
+213,300
| New | +$2.73M |
|
30
Bausch Health
BHC
$2.58B
| $2.75M | 1.08% |
+19,200
| New | +$2.58M |
|
|
NXGN
31
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.63M | 1.03% |
+168,750
| New | +$2.47M |
|
32
Agilent Technologies
A
$39.1B
| $2.58M | 1.01% |
+63,065
| New | +$2.54M |
|
33
Revvity
RVTY
$12.6B
| $2.54M | 1% |
+58,000
| New | +$2.5M |
|
|
AMSG
34
DELISTED
Amsurg Corp
AMSG
| $2.42M | 0.95% |
+44,200
| New | +$2.25M |
|
|
OCR
35
DELISTED
OMNICARE INC
OCR
| $2.41M | 0.95% |
+33,045
| New | +$2.24M |
|
36
DaVita
DVA
$15.4B
| $2.4M | 0.94% |
+31,747
| New | +$2.39M |
|
37
Merck
MRK
$322B
| $2.33M | 0.91% |
+42,973
| New | +$2.39M |
|
|
MDVN
38
DELISTED
MEDIVATION, INC.
MDVN
| $2.24M | 0.88% |
+44,900
| New | +$2.33M |
|
39
Humana
HUM
$43.7B
| $2.2M | 0.86% |
+15,298
| New | +$2.09M |
|
|
SLXP
40
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $2.19M | 0.86% |
+19,100
| New | +$2.31M |
|
41
AbbVie
ABBV
$443B
| $2.18M | 0.85% |
+33,301
| New | +$2.1M |
|
|
MDAS
42
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
| $2.09M | 0.82% |
+105,900
| New | +$2.15M |
|
|
HRC
43
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.07M | 0.81% |
+45,350
| New | +$2.01M |
|
44
Cigna
CI
$73.7B
| $1.89M | 0.74% |
+18,400
| New | +$1.81M |
|
|
CELG
45
DELISTED
Celgene Corp
CELG
| $1.72M | 0.67% |
+15,360
| New | +$1.62M |
|
|
AET
46
DELISTED
Aetna Inc
AET
| $1.7M | 0.67% |
+19,150
| New | +$1.61M |
|
|
RAD
47
DELISTED
Rite Aid Corporation
RAD
| $1.61M | 0.63% |
+10,725
| New | +$1.19M |
|
|
MGLN
48
DELISTED
Magellan Health Services, Inc.
MGLN
| $1.55M | 0.61% |
+25,820
| New | +$1.52M |
|
|
SRNE
49
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.49M | 0.59% |
+148,253
| New | +$751K |
|
|
WBA
50
DELISTED
Walgreens Boots Alliance
WBA
| $1.39M | 0.54% |
+18,200
| New | +$1.22M |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Endurant Capital Management, which disclosed 87 positions worth $255M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Thermo Fisher Scientific: 120,950 shares worth $15.2M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, followed by Technology and Financials.
- Endurant Capital Management's largest Q4 2014 buy was Thermo Fisher Scientific: 120,950 shares worth $15.2M.
- Endurant Capital Management's ten largest holdings make up 38% of its $255M portfolio in Q4 2014.
- Endurant Capital Management disclosed 87 positions in Q4 2014, its first 13F filing on record.
Based on Endurant Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.